Send us Feedback

NPS Pharmaceuticals (NPSP)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

NPSP » Topics » NPS Pharmaceuticals Announces Planned Sale of Common Stock

This excerpt taken from the NPSP 8-K filed Sep 8, 2005.

NPS Pharmaceuticals Announces Planned Sale of Common Stock

 

Salt Lake City — September 8, 2005 — NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) announced today that it is selling 7,000,000 shares of its common stock pursuant to a previously filed shelf registration statement. Lehman Brothers Inc. is acting as sole book running manager in the offering. NPS expects the closing of the offering to occur on or about September 13, 2005.

 

Additional information and details with respect to the offering will be included in a prospectus supplement that will be filed with the Securities and Exchange Commission prior to closing. When available, copies of the prospectus supplement (including the accompanying prospectus) relating to these securities may be obtained from Lehman Brothers Inc., c/o ADP Financial Services, Prospectus Fulfillment, 1155 Long Island Avenue, Edgewood, New York, 11717.

 

The matters discussed herein may contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from expectations. Certain of these risks are set forth in the Company’s Annual Report on From 10-K for the fiscal year ended December 31, 2004, the Company’s Quarterly Report on Form 10-Q for the second quarter of 2005, as well as the Company’s other reports filed with the Securities and Exchange Commission.

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki